Skip to main content
Home / Current Medicinal Chemistry, Volume 18, Number 24
Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.

Publisher: Bentham Science Publishers

More about this publication?
Volume 18, Number 24, 2011

Articles

Free Content Editorial [Hot Topic: Hot Topics in Cellular Cardiac Electrophysiology with Potential Impact on Future Drug Design (Guest Editors: Peter P. Nanasi and Valeria Kecskemeti)]
pp. 3595-3596(2)
Authors: P. Nanasi, Peter; Kecskemeti, Valeria

Favourites:
ADD

Mechanism of Reverse Rate-Dependent Action of Cardioactive Agents
pp. 3597-3606(10)
Authors: Banyasz, T.; Barandi, L.; Harmati, G.; Virag, L.; Szentandrassy, N.; Marton, I.; Zaza, A.; Varro, A.; P. Nanasi, P.

Favourites:
ADD

Enhanced Repolarization Capacity: New Potential Antiarrhythmic Strategy Based on hERG Channel Activation
pp. 3607-3621(15)
Authors: Szabo, G.; Farkas, V.; Grunnet, M.; Mohacsi, A.; P. Nanasi, P.

Favourites:
ADD

Role of Ca2+-Sensitive K+ Currents in Controlling Ventricular Repolarization: Possible Implications for Future Antiarrhytmic Drug Therapy
pp. 3622-3639(18)
Authors: Nagy, N.; Marton, Z.; Kiss, L.; Varro, A.; P. Nanasi, P.; Toth, A.

Favourites:
ADD

Sarcolemmal KATP Channel Modulators and Cardiac Arrhythmias
pp. 3640-3661(22)
Authors: Baczko, I.; Husti, Z.; Lang, V.; Lepran, I.; E. Light, P.

Favourites:
ADD

Selective Pharmacological Inhibition of the Pacemaker Channel Isoforms (HCN1-4) as New Possible Therapeutical Targets
pp. 3662-3674(13)
Authors: Koncz, I.; Szel, T.; Jaeger, K.; Baczko, I.; Cerbai, E.; N. Romanelli, M.; Gy. Papp, J.; Varro, A.

Favourites:
ADD

Atrial Remodeling and Novel Pharmacological Strategies for Antiarrhythmic Therapy in Atrial Fibrillation
pp. 3675-3694(20)
Authors: Jost, N.; Kohajda, Z.; A. Kristof, A.; P. Kovacs, P.; snm, Z.Husti; Juhasz, V.; Kiss, L.; Varro, A.; Virag, L.; Baczko, I.

Favourites:
ADD

Xanthine Derivatives in the Heart: Blessed or Cursed?
pp. 3695-3706(12)
Authors: J. Szentmiklosi, A.; Cseppento, A.; Gesztelyi, R.; Zsuga, J.; Kortvely, A.; Harmati, G.; P. Nanasi, P.

Favourites:
ADD

Cardiac Calmodulin Kinase: A Potential Target for Drug Design
pp. 3707-3713(7)
Authors: Banyasz, T.; Szentandrassy, N.; Toth, A.; P. Nanasi, P.; Magyar, J.; Chen-Izu, Y.

Favourites:
ADD

Long Term Regulation of Cardiac L-Type Calcium Channel by Small G Proteins
pp. 3714-3719(6)
Authors: Magyar, J.; Jenes, A.; Kistamas, K.; Ruzsnavszky, F.; P. Nanasi, P.; Satin, J.; Szentandrassy, N.; Banyasz, T.

Favourites:
ADD

Can the Electrophysiological Action of Rosiglitazone Explain its Cardiac Side Effects?
pp. 3720-3728(9)
Authors: Szebeni, A.; Szentandrassy, N.; Pacher, P.; Simko, J.; P. Nanasi, P.; Kecskemeti, V.

Favourites:
ADD

Modified cAMP Derivatives: Powerful Tools in Heart Research
pp. 3729-3736(8)
Authors: Szentandrassy, N.; Harmati, G.; Farkas, V.; Horvath, B.; Hegyi, B.; Magyar, J.; Szenasi, G.; Marton, I.; P. Nanasi, P.

Favourites:
ADD

Powerful Technique to Test Selectivity of Agents Acting on Cardiac Ion Channels: The Action Potential Voltage-Clamp
pp. 3737-3756(20)
Authors: Szentandrassy, N.; Nagy, D.; Ruzsnavszky, F.; Harmati, G.; Banyasz, T.; Magyar, J.; J. Szentmiklosi, A.; P. Nanasi, P.

Favourites:
ADD

Share Content

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content